Top Markets
Coin of the day
MegaPro Biomedical Co., Ltd MegaPro Biomedical Co., Ltd

MegaPro Biomedical Co., Ltd

6827
Classement en actions #28596
MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily... MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily focused on pioneering nanodrugs. Its innovative development pipeline includes MPB-1523, an IOP injection currently in Phase II clinical evaluation for addressing hepatocellular carcinoma. Simultaneously, MPB-1514, an iron injection, is also undergoing Phase II clinical trials, targeting iron deficiency anemia. Furthermore, the firm is advancing MPB-1734, an anti-cancer pharmaceutical, which is in preclinical assessment for the treatment of malignant tumors. Established in 2014, this company is headquartered in Zhubei, Taiwan.
Prix de l'action
$0.32276013
Dernière synchronisation: 2026-08-17
Capitalisation boursière
$25.60M
Changement (1 jour)
0.00%
Changement (1 an)
-38.97%
Pays
TW
Échange MegaPro Biomedical Co., Ltd (6827)

Catégorie

Historique du prix de l'action pour MegaPro Biomedical Co., Ltd (6827)
Prix de clôture le plus élevé : $0.32 le 2026-08-01

Prix de clôture le plus bas : $1.16 le 2021-10-01
Historique du prix de l'action de MegaPro Biomedical Co., Ltd de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 5.54%
2025 -10.48%
2024 -45.13%
2023 34.29%
2022 -46.18%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH